Biotech Collaborations

Search Available Compounds by Structure

List Your Company
Advertise Here
Submit Press Release

SEARCH Bio Expo Online

Home News Search Register Login

Bio Expo Online

Biotech Collaborations

5th International Summit on GMP, GCP & Quality Control on August 15-16, 2016 Toronto, Canada - Join us for the GMP Summit 2016 Conference!!!! The biggest conference gathering of the global pharma manufacturing industry, attracting attendees from around the globe. The program agenda provides a unique forum for pharmaceutical executives from around the world to network and hear world-renowned experts discussing the latest insight into the international Intellectual Property, Business Development, […]
6th BioBanking event June 20-21 2016, Holiday Inn Regents Park, London, UK - The upcoming proposed Data Protection Regulation in EU is the culmination of biobanking operations, and will constitute a new legal framework if and once passed by the European Commission. As such, SMi’s 6th Biobanking Conference will focus on the potential changes and impacts of maintaining a sustainable biobanking infrastructure, harmonisation and interaction between biobanks across […]
Academic Drug Discovery 2016 March 22-23 2016 Cambridge, UK - SELECTBIO is pleased to announce Academic Drug Discovery 2016, which will be held on 22 – 23 March 2016 in Cambridge, UK. The event is part of our Cambridge Workshop Series. Attracting a global audience of researchers, academics, group leaders, directors and the global heads of leading academic and open innovation drug discovery centres, this […]
XL-protein Signs Licensing Agreement with MSD Animal Health to Develop Biopharmaceuticals Using its PASylation® Technology - FREISING, GERMANY, February 12, 2015 – XL-protein GmbH, Germany, a privately owned biopharmaceutical company, announced today that they have entered into a license agreement with MSD Animal Health (known as Merck Animal Health in the USA and Canada) to develop PASylated biopharmaceuticals for use in animal health. This license agreement follows a research collaboration between […]
FMC 2015 – Frontiers in Medicinal Chemistry Antwerp, Belgium – September 14-16, 2015 - The Frontiers in Medicinal Chemistry symposium is co-organised on a biennial basis, as a collaboration between the ACS (American Chemical Society) and the EFMC (European Federation for Medicinal Chemistry). Frontiers 2015 will take place in Antwerp, Belgium, from September 14-16, 2015. It will be jointly organised by EFMC, ACS and the local Dutch and Belgian […]
Academic Drug Discovery, 19-20 May, Cambridge, UK - SELECTBIO’s Academic Drug Discovery 2015, Cambridge, UK, will be a progression from our successful academic discovery events in the USA. Creating a European platform to bridge the gap between basic research and commercial application for innovative technologies. With talks from global experts on partnering models between both industrial and academic organizations that have successfully contributed […]
UCSF, Stanford and Johns Hopkins join FDA partnership to speed drug development - At a time when Big Pharma is increasingly tapping academic institutions for expertise in informatics and data-driven computer models for drug discovery, the FDA has selected Johns Hopkins University, Stanford University and the University of California, San Francisco (UCSF) for a new initiative aimed at streamlining the drug development and approval process. Under the FDA’s […]
Canada to set up cancer cloud computing facility - Recognition of the insights hidden in genetic data and the difficulty in extracting them has prompted governments around the world to stump up cash for informatics projects. Canada is set to continue upping its investments in the field, with a cancer cloud computing facility the latest project to secure financial backing. The Natural Sciences and […]
Researchers create protein with potential for weight loss - It sounds like a magic bullet: Administer a protein, watch the subject lose weight. But that’s exactly what University of Florida scientists found when they discovered a new way to deliver a protein that helps develop cells that convert fat into energy. The study builds upon on a discovery by Bruce Spiegelman, a cell biologist […]
Remarkable Twin Study Widens View of Down’s Syndrome - A large coalition of European and American researchers this week published a new gene expression study of trisomy 21, better known as Down’s syndrome, using a novel cellular model of the disorder. Induced pluripotent stem cells were derived from a set of identical twins, only one of which possessed the third copy of chromosome 21 […]
New Protein Finding Gives Hope to Infertility Patients - Answering the question of “how do babies come in this world” is not easy at any age. You may laugh now, but as children we all heard the stories about some birds and some bees, some storks or other similar versions, while as adults, we are probably telling our children the same tales, so they […]
Experimental drug could thwart measles outbreaks - A new antiviral drug may provide an effective way to treat measles in those who have not been vaccinated. When tested in an oral form in animals infected with a similar version of the measles virus, the experimental drug not only prevented animals from dying of the disease, but it significantly reduced virus levels. Developed […]
Good vibrations: Using light-heated water to deliver drugs - Researchers from the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, in collaboration with materials scientists, engineers and neurobiologists, have discovered a new mechanism for using light to activate drug-delivering nanoparticles and other targeted therapeutic substances inside the body. This discovery represents a major innovation, said Adah Almutairi, PhD, associate professor […]
GlaxoSmithKline joins a $115M antibiotics development initiative - Resistance to antibacterials is fast becoming one of the most urgent public health problems, especially since the pipeline for new antibiotics largely has dried up after Big Pharma’s retreat from the field in recent years. To help combat growing antimicrobial resistance, more than 30 European universities, research institutions and drug companies are joining together to […]
11th Anti-infectives Partnering and Deal-Making Conference (July 10-11, 2014, Boston, MA) - GTC’s 11th Anti-infectives Partnering and Deal-Making Conference, taking place on July 10-11, 2014 in Boston, MA, will contribute to the on-going battle against the ever-changing infectious threats by having experts with direct experiences in the field discuss a wide variety of topics on infectious diseases. The agenda also allows time for networking and opportunities to […]
Big Pharma superteam joins NIH to share data - The National Institutes of Health has persuaded 10 rival drugmakers to briefly set aside their competitive spirits and collaborate on drug discovery projects in four major diseases, pooling their data and expertise to kick-start early-stage efforts. Under the 5-year plan, the drugmakers will contribute some of their brightest minds in Alzheimer’s, Type 2 diabetes, rheumatoid […]
Sony teams with Illumina working on Japanese genome market - Sony has struggled financially in recent years, with its shrinking share of the TV market and a sector-wide slump in PC sales dragging the company down. With the electronics business floundering, management is looking to other sectors to prop up the business and thinks it has found the next growth engine–genomics. The Japanese business ($SNE) […]
Biogen Idec, Proteostasis forge neurodegenerative pact - CAMBRIDGE, Mass.—Alzheimer’s disease, and some of its neurodegenerative cousins, came under fire from a new direction as Proteostasis Therapeutics Inc. this month brought in the R&D and clinical firepower of fellow Cambridge-based company Biogen Idec. in a worldwide collaboration agreement. The deal combines Proteostasis Therapeutics’ proprietary scientific platform and preclinical work on protein degradation with […]
Immunocore and GlaxoSmithKline team to work on immunotherapies - Immunocore’s list of collaborators is beginning to look like a Who’s Who in Big Pharma. Today the biotech–which is developing T cell immunotherapy technology originally spun out of Oxford–added a deal-hungry AstraZeneca ($AZN) and its biologics team at MedImmune as its latest partner, which will now join Genentech and GlaxoSmithKline in exploring whether the biotech […]
Celgene, Lilly back $100M VC for biotech startups in NYC - Three big players in the life sciences industry–Celgene ($CELG), Eli Lilly ($LLY) and GE Ventures–are chipping in to help fund a $100 million venture fund that will be used to launch up to 20 new biotech companies in New York City, adding some fuel to a small but growing fire of R&D efforts in the […]

Category List
A to Z Company List
Allied Services
Building Blocks
Company Type
Contract Research, Procurement Services
Custom Synthesis
Logistics, Packaging, Shipping
Name Reactions
Natural Products
Process Services
Scientific Equipment
Screening Compounds
Specialty Chemicals
Volume Capacity
Web Links
Conferences and Trade Shows

News and Events

Media Partners
Become a Partner

Our Services
Advertisement on
Contact BioExpoOnline
Link to BioExpoOnline
Media Partners
Partner with BioExpoOnline
Privacy and Terms of Use

Featured Links

LOPAC 1280
Search by Structure
Bioscreening News
Chemical Reagents
Chemistry Software
Chemistry Databases

Home | News | Advanced Search | List Your Company | Advertising | Terms | Account Login | Contact Us

2004-2007, All Rights Reserved